XML 82 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 13 - Segment Data
 12 Months Ended
Mar. 31, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]

Note 13. Segment Data


Prior to the November 2013 acquisitions of TempSys and Amega, we had two reporting segments: Biological Indicators and Instruments. As a result of these acquisitions, we now have a third reporting segment, Continuous Monitoring. The following tables set forth our segment information (in thousands):


   

Year Ended March 31, 2014

 
   

Biological

Indicators

   

Instruments

   

Continuous Monitoring

   

Total

 

Revenues

  $ 22,992     $ 26,389     $ 3,343     $ 52,724  
                                 

Gross profit

  $ 13,187     $ 16,904     $ 1,597     $ 31,688  

Selling expenses

    1,350       3,954       815       6,119  
    $ 11,837     $ 12,950     $ 782       25,569  

Reconciling items (1)

                            (12,466 )

Earnings before income taxes

                          $ 13,103  

   

Year Ended March 31, 2013

 
   

Biological

Indicators

   

Instruments

   

Continuous Monitoring

   

Total

 

Revenues

  $ 21,464     $ 24,971     $ --     $ 46,435  
                                 

Gross profit

  $ 12,365     $ 16,497     $ --     $ 28,862  

Selling expenses

    1,552       3,078       --       4,630  
    $ 10,813     $ 13,419     $ --       24,232  

Reconciling items (1)

                            (11,254 )

Earnings before income taxes

                          $ 12,978  

   

Year Ended March 31, 2012

 
   

Biological

Indicators

   

Instruments

   

Continuous Monitoring

   

Total

 

Revenues

  $ 20,422     $ 19,194     $ --     $ 39,616  
                                 

Gross profit

  $ 11,236     $ 12,275     $ --     $ 23,511  

Selling expenses

    1,607       2,302       --       3,909  

Impairment of intangible asset

    --       350               350  
    $ 9,629     $ 9,623     $ --       19,252  

Reconciling items (1)

                            (6,921 )

Earnings before income taxes

                          $ 12,331  

(1) Reconciling items include general and administrative, research and development, and other expenses.


Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):


   

Year Ended March 31,

 
   

2014

   

2013

   

2012

 

Revenues from unaffiliated customers

                       

United States

  $ 29,551     $ 28,590     $ 23,770  

Foreign

    23,173       17,845       15,846  
    $ 52,724     $ 46,435     $ 39,616  

   

March 31,

 
   

2014

   

2013

 

Total assets

               

Biological Indicators

  $ 22,771     $ 27,558  

Instruments

    36,797       31,782  

Continuous Monitoring

    28,578       --  

Corporate and administrative

    9,383       6,579  
    $ 97,529     $ 65,919  

All long-lived assets are located in the United States.